Jazz Pharmaceuticals (United States)

Jazz Pharmaceuticals (United States)

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Jazz Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

63%


Total
Publications

758


Total Open
Publications

479


Total
Citations

14K


Open Access
Percentage

63%


Total
Publications

758


Total Open
Publications

479


Total
Citations

14K

Wikipedia

Website

download

Breakdown

38% 21% 4% 37%

Publisher Open

38%

Both

21%

Other Platform Open

4%

Closed

37%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

18%OA Journal

OA Journal 18%

82

Hybrid 36%

163

No Guarantees 46%

205

Other Platform Open

Domain 93%

177

Institution 20%

39

Other Internet 8%

16

Public 4%

8

Preprint 3%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
176
Europe PMC
Domain
72
University of California - eScholarship University of California
Institution
7
Semantic Scholar
Public
7
University College London - UCL Discovery
Institution
6
California Digital Library - eScholarship
Other Internet
6
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
5
University of Michigan - Deep Blue
Institution
4
Aalborg Universitet - VBN Forskningsportal
Other Internet
4
Université de Montréal - Papyrus : Institutional Repository
Institution
3
1 / 6

Data updated 8 December 2024

Share

Share

Share